Figure 1.
Proportion of patients newly initiating beta blockers, ACEI/ARB, all and high-potency statins after hospitalization for myocardial infarction by year.
ACEI/ARB: angiotensin-converting enzyme inhibitors/angiotensin receptor blockers
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.